(Q33366493)

English

The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

thrombocytopenia

1 reference

based on heuristic

inferred from title

thrombotic thrombocytopenic purpura

1 reference

based on heuristic

inferred from title

author name string

Martina Böhm

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Christoph Betz

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Wolfgang Miesbach

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Manuela Krause

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Charis von Auer

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Helmut Geiger

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Inge Scharrer

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

1 June 2005

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

129

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

644-652

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

Mutation analysis and clinical implications of von Willebrand factor-cleaving protease deficiency

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

Evaluation and clinical application of a new method for measuring activity of von Willebrand factor-cleaving metalloprotease (ADAMTS13).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

Vincristine as treatment for recurrent episodes of thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

Plasma therapy in thrombotic thrombocytopenic purpura: review of the literature and the Bern experience in a subgroup of patients with severe acquired ADAMTS-13 deficiency

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

Partial amino acid sequence of purified von Willebrand factor-cleaving protease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

Immunoadsorption for the treatment of a patient with severe thrombotic thrombocytopenic purpura resistant to plasma exchange: kinetics of an inhibitor of ADAMTS13.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

Molecular characterization of ADAMTS13 gene mutations in Japanese patients with Upshaw-Schulman syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

Thrombotic thrombocytopenic purpura: the systemic clumping "plague".

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

Congenital thrombotic thrombocytopenic purpura in association with a mutation in the second CUB domain of ADAMTS13

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

High titers of inhibitors of von Willebrand factor-cleaving metalloproteinase in a fatal case of acute thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

Ten candidate ADAMTS13 mutations in six French families with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05512.X

21 January 2018

Identifiers

10.1111/J.1365-2141.2005.05512.X

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33366493&oldid=1980263683"